Caplin Point Laboratories consolidated net profit rises 19.32% in the March 2026 quarter

Sales rise 19.45% to Rs 600.16 crore

Net profit of Caplin Point Laboratories rose 19.32% to Rs 170.11 crore in the quarter ended March 2026 as against Rs 142.57 crore during the previous quarter ended March 2025. Sales rose 19.45% to Rs 600.16 crore in the quarter ended March 2026 as against Rs 502.45 crore during the previous quarter ended March 2025.

For the full year,net profit rose 19.57% to Rs 641.24 crore in the year ended March 2026 as against Rs 536.31 crore during the previous year ended March 2025. Sales rose 12.89% to Rs 2187.19 crore in the year ended March 2026 as against Rs 1937.47 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	600.16	502.45	19	2187.19	1937.47	13
OPM %	34.03	33.45	-	34.79	33.39	-
PBDT	232.24	193.71	20	875.56	742.74	18
PBT	213.44	176.67	21	802.79	676.78	19
NP	170.11	142.57	19	641.24	536.31	20

Powered by Capital Market - Live News